Home
Jazz Pharmaceuticals and Zymeworks Product Zanidatamab Advance the Treatment of HER2-expressing mGA

Jazz Pharmaceuticals and Zymeworks Product Zanidatamab Advance the Treatment of HER2-expressing mGA

Impacting News January 20, 2023

Jazz Pharmaceuticals and Zymeworks Inc Announce Results of Zanidatamab
Jazz Pharmaceuticals (JAZZ) and Zymeworks Inc. (ZYME)

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Impacting News
,
January 20, 2023

Other Articles